Study Shows Eritoran Can Protect Against Lethal Flu Infection

New Drug Approvals

File:Eritoran free acid skeletal.svg


read all at

Eritoran is an investigational drug for the treatment of severe sepsis, an excessiveinflammatory response to an infection. It is being developed by the Japanese pharmaceutical company Eisai Co. and administered intravenously as the sodium salteritoran tetrasodium.

In a phase III clinical trial, eritoran did not perform better than existing treatments for the treatment of sepsis

View original post


About luciavazine

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s